These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17048506)

  • 1. Arsonoliposome interaction with thiols: effect of pegylation and arsonolipid content of arsonoliposomes on their integrity during incubation in glutathione.
    Haikou MN; Zagana P; Ioannou PV; Antimisiaris SG
    J Nanosci Nanotechnol; 2006; 6(9-10):2974-8. PubMed ID: 17048506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles.
    Piperoudi S; Fatouros D; Ioannou PV; Frederik P; Antimisiaris SG
    Chem Phys Lipids; 2006 Feb; 139(2):96-106. PubMed ID: 16405880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsonoliposomes: effect of lipid composition on their stability and morphology.
    Piperoudi S; Ioannou PV; Frederik P; Antimisiaris SG
    J Liposome Res; 2005; 15(3-4):187-97. PubMed ID: 16393910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsonoliposomes: novel nanosized arsenic-containing vesicles for drug delivery.
    Fatouros DG; Ioannou PV; Antimisiaris SG
    J Nanosci Nanotechnol; 2006; 6(9-10):2618-37. PubMed ID: 17048471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture.
    Gortzi O; Antimisiaris SG; Klepetsanis P; Papadimitriou E; Ioannou PV
    Eur J Pharm Sci; 2003 Feb; 18(2):175-83. PubMed ID: 12594011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation.
    Mourtas S; Michanetzis GP; Missirlis YF; Antimisiaris SG
    J Biomed Nanotechnol; 2009 Aug; 5(4):409-15. PubMed ID: 20055087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo distribution of arsonoliposomes: effect of vesicle lipid composition.
    Zagana P; Haikou M; Klepetsanis P; Giannopoulou E; Ioannou PV; Antimisiaris SG
    Int J Pharm; 2008 Jan; 347(1-2):86-92. PubMed ID: 17689900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the lipid membrane composition of arsonoliposomes affect their anticancer activity? A cell culture study.
    Zagana P; Haikou M; Giannopoulou E; Ioannou PV; Antimisiaris SG
    Mol Nutr Food Res; 2009 May; 53(5):592-9. PubMed ID: 18727012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and aggregation studies of non-sonicated arsonolipid-containing vesicles.
    Fatouros DG; Bouropoulos N; Ioannou PV; Antimisiaris SG
    Cell Mol Biol Lett; 2005; 10(1):173-83. PubMed ID: 15809688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanocidal activity of arsonoliposomes: effect of vesicle lipid composition.
    Zagana P; Klepetsanis P; Ioannou PV; Loiseau PM; Antimisiaris SG
    Biomed Pharmacother; 2007 Sep; 61(8):499-504. PubMed ID: 17606357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical stability of sonicated arsonoliposomes: effect of calcium ions.
    Fatouros DG; Piperoudi S; Gortzi O; Ioannou PV; Frederik P; Antimisiaris SG
    J Pharm Sci; 2005 Jan; 94(1):46-55. PubMed ID: 15761929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types.
    Mourtas S; Papadia K; Kordopati GG; Ioannou PV; Antimisiaris SG; Tsivgoulis GM
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and properties of arsonolipid containing liposomes.
    Fatouros D; Gortzi O; Klepetsanis P; Antimisiaris SG; Stuart MC; Brisson A; Ioannou PV
    Chem Phys Lipids; 2001 Jan; 109(1):75-89. PubMed ID: 11163346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal behavior of novel non-sonicated arsonolipid-containing liposomes.
    Koutsopoulos S; Fatouros DG; Ioannou PV; Antimisiaris SG
    Biophys Chem; 2006 May; 121(2):150-4. PubMed ID: 16472907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pH on the electrophoretic behaviour of a new class of liposomes: arsonoliposomes.
    Fatouros DG; Klepetsanis P; Ioannou PV; Antimisiaris SG
    Int J Pharm; 2005 Jan; 288(1):151-6. PubMed ID: 15607267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture.
    Gortzi O; Papadimitriou E; Kontoyannis CG; Antimisiaris SG; Ioannou PV
    Pharm Res; 2002 Jan; 19(1):79-86. PubMed ID: 11837704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice.
    Antimisiaris SG; Ioannou PV; Loiseau PM
    J Pharm Pharmacol; 2003 May; 55(5):647-52. PubMed ID: 12831507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsonoliposomes: preparation and physicochemical characterization.
    Antimisiaris SG; Ioannou PV
    Methods Mol Biol; 2010; 605():147-62. PubMed ID: 20072879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes.
    Zagana P; Mourtas S; Basta A; Antimisiaris SG
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32268585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsonoliposomes for the potential treatment of medulloblastoma.
    Favretto ME; Marouf S; Ioannou P; Antimisiaris SG; Parker TL; Kallinteri P
    Pharm Res; 2009 Oct; 26(10):2237-46. PubMed ID: 19626426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.